J. Illambas

475 total citations
19 papers, 385 citations indexed

About

J. Illambas is a scholar working on Microbiology, Pharmacology and Epidemiology. According to data from OpenAlex, J. Illambas has authored 19 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Microbiology, 10 papers in Pharmacology and 6 papers in Epidemiology. Recurrent topics in J. Illambas's work include Microbial infections and disease research (11 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Pneumonia and Respiratory Infections (3 papers). J. Illambas is often cited by papers focused on Microbial infections and disease research (11 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Pneumonia and Respiratory Infections (3 papers). J. Illambas collaborates with scholars based in United Kingdom, United States and France. J. Illambas's co-authors include P. Lees, Timothy Potter, Andrew N. Rycroft, Ludovic Pelligand, Pierre‐Louis Toutain, Marlène Z. Lacroix, Pritam K. Sidhu, Stephen E. Wilson, Sean P. Mahabir and Csilla Becskei and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Vaccine and Veterinary Parasitology.

In The Last Decade

J. Illambas

19 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Illambas United Kingdom 11 198 145 108 83 68 19 385
Patxi Sarasola United Kingdom 11 97 0.5× 87 0.6× 102 0.9× 35 0.4× 26 0.4× 20 355
T. L. Skogerboe United States 13 124 0.6× 218 1.5× 80 0.7× 40 0.5× 35 0.5× 27 485
C. Giles United Kingdom 11 98 0.5× 129 0.9× 25 0.2× 55 0.7× 66 1.0× 22 429
Dieter Vancraeynest Belgium 14 91 0.5× 57 0.4× 262 2.4× 37 0.4× 11 0.2× 26 529
J.P. Crane United States 9 143 0.7× 31 0.2× 73 0.7× 110 1.3× 9 0.1× 13 463
Bernd Stephan Germany 11 95 0.5× 46 0.3× 51 0.5× 136 1.6× 44 0.6× 13 407
Fen Qu China 15 76 0.4× 22 0.2× 160 1.5× 246 3.0× 17 0.3× 35 556
A P Kuritza United States 11 58 0.3× 24 0.2× 201 1.9× 30 0.4× 51 0.8× 14 487
Thaís Sebastiana Porfida Ferreira Brazil 11 16 0.1× 81 0.6× 50 0.5× 42 0.5× 41 0.6× 27 341
Kevin Godinho United Kingdom 11 44 0.2× 196 1.4× 61 0.6× 85 1.0× 6 0.1× 13 391

Countries citing papers authored by J. Illambas

Since Specialization
Citations

This map shows the geographic impact of J. Illambas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Illambas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Illambas more than expected).

Fields of papers citing papers by J. Illambas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Illambas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Illambas. The network helps show where J. Illambas may publish in the future.

Co-authorship network of co-authors of J. Illambas

This figure shows the co-authorship network connecting the top 25 collaborators of J. Illambas. A scholar is included among the top collaborators of J. Illambas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Illambas. J. Illambas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Huddart, Robert, Ann Henry, Vincent Khoo, et al.. (2017). Toxicity and Survival Outcomes of a Randomized Phase 2 Trial of Hypofractionated Bladder Radiation Therapy in an Elderly Population With or Without Image Guided Adaptive Plan Selection (HYBRID - CRUK/12/055). International Journal of Radiation Oncology*Biology*Physics. 99(2). S118–S119. 2 indexed citations
2.
Lees, P., J. Illambas, Ludovic Pelligand, & Pierre‐Louis Toutain. (2016). Comparison of standardised versus non-standardised methods for testing the in vitro potency of oxytetracycline against Mannheimia haemolytica and Pasteurella multocida. The Veterinary Journal. 218. 60–64. 5 indexed citations
4.
Becskei, Csilla, J. Illambas, Judith A. Cherni, et al.. (2016). Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™), for the treatment of sarcoptic mange in dogs. Veterinary Parasitology. 222. 56–61. 38 indexed citations
5.
Toutain, Pierre‐Louis, Timothy Potter, Ludovic Pelligand, et al.. (2016). Standard PK/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf. Journal of Veterinary Pharmacology and Therapeutics. 40(1). 16–27. 48 indexed citations
6.
Lees, P., J. Illambas, Timothy J. Potter, et al.. (2016). A large potentiation effect of serum on the in vitro potency of tulathromycin against Mannheimia haemolytica and Pasteurella multocida. Journal of Veterinary Pharmacology and Therapeutics. 40(5). 419–428. 17 indexed citations
7.
Lewis, Rebecca, S. Hafeez, H. McNair, et al.. (2015). Remote training solutions for complex intervention trials. Trials. 16(S2). 1 indexed citations
8.
Lees, P., Ludovic Pelligand, J. Illambas, et al.. (2015). Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogensMannheimia haemolyticaandPasteurella multocida. Journal of Veterinary Pharmacology and Therapeutics. 38(5). 457–470. 29 indexed citations
9.
Wilson, Stephen E., et al.. (2014). Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c. Vaccine. 32(42). 5420–5424. 43 indexed citations
11.
Wilson, Stephen E., et al.. (2013). Duration of immunity of a multivalent (DHPPi/L4R) canine vaccine against four Leptospira serovars. Vaccine. 31(31). 3126–3130. 23 indexed citations
12.
Illambas, J., Timothy Potter, Zhangrui Cheng, et al.. (2013). Pharmacodynamics of marbofloxacin for calf pneumonia pathogens. Research in Veterinary Science. 94(3). 675–681. 18 indexed citations
13.
Sidhu, Pritam K., Ali Rassouli, J. Illambas, et al.. (2013). Pharmacokinetic–pharmacodynamic integration and modelling of florfenicol in calves. Journal of Veterinary Pharmacology and Therapeutics. 37(3). 231–242. 50 indexed citations
15.
Illambas, J., Timothy Potter, Pritam K. Sidhu, et al.. (2013). Pharmacodynamics of florfenicol for calf pneumonia pathogens. Veterinary Record. 172(13). 340–340. 22 indexed citations
16.
Potter, Timothy, J. Illambas, Ludovic Pelligand, Andrew N. Rycroft, & P. Lees. (2012). Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida. The Veterinary Journal. 195(1). 53–58. 34 indexed citations
17.
18.
Sidhu, Pritam K., J. Illambas, Timothy J. Potter, Andrew N. Rycroft, & P. Lees. (2009). Pharmacokinetics and pharmacodynamics of florfenicol in calves. View. 2 indexed citations
19.
Illambas, J., Timothy Potter, Andrew N. Rycroft, & P. Lees. (2009). Pharmacodynamics of tulathromycin in vitro and ex vivo against calf pathogens. RVC Research Online (Royal Veterinary College). 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026